Nyxoah SA (NYXH) Prices 2.835M Share IPO at $30/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Nyxoah Announces Pricing of Nasdaq Public Offering
July 2, 2021 8:40 AM EDTMont-Saint-Guibert, Belgium July 2, 2021, 2:40pm CET / 8:40am ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (Nyxoah or the Company), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the pricing of its initial public offering in the United States (the "Offering") of 2,835,000 ordinary shares at a price to the public of US$Â 30 per share for total gross proceeds of US$Â 85.1 million before deducting underwriting discounts and commissions and estimated offering expenses.
In addition, Nyxoah has granted the... More
